Osteoactivin inhibition of osteoclastogenesis is mediated through CD44-ERK signaling

Osteoactivin is a heavily glycosylated protein shown to have a role in bone remodeling. Previous studies from our lab have shown that mutation in Osteoactivin enhances osteoclast differentiation but inhibits their function. To date, a classical receptor and a signaling pathway for Osteoactivin-media...

Descripción completa

Detalles Bibliográficos
Autores principales: Sondag, Gregory R, Mbimba, Thomas S, Moussa, Fouad M, Novak, Kimberly, Yu, Bing, Jaber, Fatima A, Abdelmagid, Samir M, Geldenhuys, Werner J, Safadi, Fayez F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5050297/
https://www.ncbi.nlm.nih.gov/pubmed/27585719
http://dx.doi.org/10.1038/emm.2016.78

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5050297/
https://www.ncbi.nlm.nih.gov/pubmed/27585719
http://dx.doi.org/10.1038/emm.2016.78

Ejemplares similares